Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001869338-22-000001
Filing Date
2022-06-15
Accepted
2022-06-15 14:56:53
Documents
1
Effectiveness Date
2022-06-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7892
  Complete submission text file 0001869338-22-000001.txt   8940
Mailing Address 215 N NEW RIVER DR. E 4200 FORT LAUDERDALE FL 33301
Business Address 215 N NEW RIVER DR. E 4200 FORT LAUDERDALE FL 33301 630-886-7345
ADvantage Therapeutics, Inc. (Filer) CIK: 0001869338 (see all company filings)

EIN.: 863737093 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-449324 | Film No.: 221017569